Related Experiment Video

Updated: Jun 30, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

[Hepatitis B in Poland in 2006]

Mirosław P Czarkowski1, Dominika Bobel

  • 1Zakład Epidemiologii, Narodowy Instytut Zdrowia Publicznego- PZH, Warszawa. mpc@pzh.gov.pl

Przeglad Epidemiologiczny
|September 24, 2008
PubMed

Insights

In 2006, Poland reported 1,693 hepatitis B cases. Chronic hepatitis B was more common than acute, with incidence varying significantly by region, age, and urban versus rural settings.

Area of Science:

  • Hepatology
  • Infectious Diseases Epidemiology
  • Public Health Surveillance

Context:

  • Hepatitis B remains a significant public health concern globally.
  • Understanding regional and demographic variations in incidence is crucial for targeted interventions.
  • Poland's 2006 data provides a snapshot of the hepatitis B epidemiological landscape.

Purpose:

  • To analyze the incidence and characteristics of hepatitis B cases reported in Poland in 2006.
  • To identify regional, demographic, and clinical patterns of hepatitis B infection.
  • To assess hospitalization rates and mortality associated with hepatitis B.

Summary:

  • A total of 1,693 hepatitis B cases were reported in Poland in 2006, with an overall incidence of 4.4 per 100,000 population.
  • Chronic hepatitis B constituted 70% of cases, with significant regional variations in incidence.
  • Higher incidence was observed in urban areas, among men, and in specific age groups, with 64 deaths attributed to the disease.

Impact:

  • The findings highlight the need for geographically tailored hepatitis B prevention and control strategies.
  • Identifying high-risk populations can inform public health resource allocation.
  • Data on hospitalization and mortality underscores the severity of hepatitis B and the importance of timely medical care.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...